Heart Disease Trial, Recruiting NCT06316349 Sponsor: University of Sao Paulo General Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06316349
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have had an intra-aortic balloon pump (a device placed in the aorta to help the heart pump blood) in place for more than 48 hours
  • People receiving a heart-stimulating medication called dobutamine at a low dose (no more than 20 mcg/kg/min)
  • People receiving a blood pressure-supporting medication called norepinephrine at a low dose (no more than 0.2 mcg/kg/min)
  • People who have not had any device problems or bleeding episodes in the past 24 hours
  • People whose average blood pressure is within a specific range (between 60 and 120 mmHg)
  • People whose heart rate is within a specific range (between 60 and 120 beats per minute)
  • People who have not had a brain or nervous system event that left lasting thinking or movement problems
  • People who have an untreated blood clot in a deep vein
  • People with no history of autoimmune disease (conditions where the immune system attacks the body)
  • People with no history of rheumatic disease (conditions affecting the joints, muscles, or connective tissue)

Who may not be able to join:

  • People who need a breathing machine (invasive mechanical ventilation) to support their breathing
  • People — or whose responsible family member — have not signed the informed consent form, or who have withdrawn their consent to participate
  • People whose norepinephrine dose needs to increase above 0.2 mcg/kg/min during the trial
  • People who develop a sudden, serious irregular heart rhythm that causes unstable blood pressure or circulation
  • People whose blood pressure or heart rate moves outside the required ranges during the trial
  • People who experience a new brain or nervous system event that causes thinking or movement problems during the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rafael M Ianotti, PT, Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Phone: +55 11 26615319

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 June 2024
Est. completion
18 March 2025

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

To investigate echo intensity of the rectus femoris muscle.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov